Padeliporfin (WST09)

padeliporfin · Steba Biotech

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Padeliporfin (WST09), covering 2010-06-02 to 2010-06-02. Get the full timeline:

Most recent: Clinical Trial Update: Phase II/III Study of WST09 in Prostate Cancer After Radiation Therapy [Phase 2, Phase 3]